about
Heterologous ("nonspecific") and sex-differential effects of vaccines: epidemiology, clinical trials, and emerging immunologic mechanismsImmune response to vaccine adjuvants during the first year of lifeAge at Mycobacterium bovis BCG Priming Has Limited Impact on Anti-Tuberculosis Immunity Boosted by Respiratory Mucosal AdHu5Ag85A Immunization in a Murine ModelNeonatal mucosal immunization with a non-living, non-genetically modified Lactococcus lactis vaccine carrier induces systemic and local Th1-type immunity and protects against lethal bacterial infection.Role of innate host defenses in susceptibility to early-onset neonatal sepsis.Development of newborn and infant vaccinesHMGB1 and cord blood: its role as immuno-adjuvant factor in innate immunity.Immunogenicity of recombinant hepatitis B vaccine: comparison of two different vaccination schedulesHepatitis B vaccination of male neonates and autism diagnosis, NHIS 1997-2002.The ultra-potent and selective TLR8 agonist VTX-294 activates human newborn and adult leukocytes.Novel probiotic Bifidobacterium longum subsp. infantis CECT 7210 strain active against rotavirus infections.Inclusion of Flagellin during Vaccination against Influenza Enhances Recall Responses in Nonhuman Primate Neonates.Delayed BCG vaccination results in minimal alterations in T cell immunogenicity of acellular pertussis and tetanus immunizations in HIV-exposed infantsImidazoquinoline Toll-like receptor 8 agonists activate human newborn monocytes and dendritic cells through adenosine-refractory and caspase-1-dependent pathways.Identification of a Peptide Produced by Bifidobacterium longum CECT 7210 with Antirotaviral Activity.Neonatal immunization with respiratory syncytial virus glycoprotein fragment induces protective immunity in the presence of maternal antibodies in mice.Effect of maternal immune status on responsiveness of bacillus calmette-gurin vaccination in mouse neonates.Economic evaluation on infant hepatitis B vaccination combined with immunoglobulin in China, 2013Immunogenicity of Recombinant Hepatitis B Vaccine Among Routinely Vaccinated Healthy and Chronically Ill Children in Assiut, Upper EgyptDevelopmental biology of the innate immune response: implications for neonatal and infant vaccine development.Neonatal BCG vaccination is associated with enhanced T-helper 1 immune responses to heterologous infant vaccines.Protecting newborns by immunizing family members in a hospital-based vaccine clinic: a successful Tdap cocooning program during the 2010 California pertussis epidemic.Assessment of Immunization to Hepatitis B Vaccine among Children under Five Years in Rural Areas of Taiz, Yemen.TLR7/8 adjuvant overcomes newborn hyporesponsiveness to pneumococcal conjugate vaccine at birth.Understanding respiratory syncytial virus (RSV) vaccine development and aspects of disease pathogenesis.Toll-like receptor 8 agonist nanoparticles mimic immunomodulating effects of the live BCG vaccine and enhance neonatal innate and adaptive immune responses.Management of Rabies Prophylaxis for Potential Bat Exposures in a Level III Neonatal Intensive Care Unit.Is Infant Immunity Actively Suppressed or Immature?Inflammatory responses to hepatitis B virus vaccine in healthy term infants.Vaccine responses in newborns.Neonates harbour highly active gammadelta T cells with selective impairments in preterm infants.Efficacy and synergy of live-attenuated and inactivated influenza vaccines in young chickens.
P2860
Q26864779-1BB0DDBD-10BD-4911-B1FC-26370C3F1D29Q27016633-61C59307-BFA7-405B-A08D-C86EF10C632BQ30375962-2E8C8089-A34B-425F-9415-3935F003B859Q33824760-EE1544C4-1952-45B2-86C0-642B207E496EQ33940417-ABED68C6-B5E0-4086-BE59-084255BF7BD3Q33941914-3E4F27BF-957D-4928-A715-3DE10E44E42FQ34018807-78C982D9-77B5-4C80-8EFC-94B716D790C8Q34021203-12F1AD21-C7ED-45FD-8D96-84543179436CQ34148633-3C2AEB6E-8D8F-43E7-84BC-B0FE07504050Q34618662-6139F05A-EC50-4451-827E-B1C6BCC5B14BQ35599181-35DC1861-0CF5-4F3D-8AE1-51C3C1BEC2BDQ35758568-1AF5E5F8-69B1-4BB8-B3FB-0014DC2E104CQ36037618-69EE47FA-8CAD-4F0A-AE9F-C31197AC8AF0Q36069620-BB9F5DDC-B8DD-4A92-88BD-806619799836Q36864224-2E9BC074-D3E2-4ED5-9159-1B218C2F70FDQ37086092-A2C24082-BD86-4AA2-A4A6-2E1B57CCF679Q37105797-88E664D5-9DC8-4D00-8A40-110BEB5C69EDQ37135465-A689AE8D-64A5-46E3-B8A1-6C8ACE2877FBQ37292882-B360B6FF-1D2E-4ED1-8D1B-804FD034DB89Q37482390-F45C21AB-968C-4537-8731-7FDF5FF83406Q37618648-C6FB9EC6-3DCC-49A8-BED8-BFD0A2764D6FQ37696100-3AF1F753-87B3-465D-8E7D-2035872AB943Q37711686-C338FE9C-85DD-4FFE-B1CF-93BAF84B22AAQ37713832-B192123B-8897-4B74-BC43-3E70D03151A8Q38660842-DEF6B499-7701-438A-B0C1-A3C5AB2C092BQ40278311-924E70BD-80F2-4D97-9AE5-51F22CF964E6Q40405290-BDC9CF66-CD39-40D5-A8EE-0C734CC6BC92Q41646010-21ED7959-14A1-4EF7-9EAC-F23191C5C308Q44631937-097A3EF4-33E7-46A2-BCDF-4D3B48793639Q46301580-2520E9E1-A69B-457C-8BF5-EF17307A51CCQ51932135-EEF4D7E1-FE62-41D2-B8DB-032C4F207C3FQ52602647-265DE29C-27C3-475D-8A35-D6BC9848B943
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Safety and efficacy of neonatal vaccination.
@en
Safety and efficacy of neonatal vaccination.
@nl
type
label
Safety and efficacy of neonatal vaccination.
@en
Safety and efficacy of neonatal vaccination.
@nl
prefLabel
Safety and efficacy of neonatal vaccination.
@en
Safety and efficacy of neonatal vaccination.
@nl
P2860
P356
P1476
Safety and efficacy of neonatal vaccination.
@en
P2093
Alicia Demirjian
P2860
P356
10.1002/EJI.200838620
P407
P577
2009-01-01T00:00:00Z